In this report, the Chemical & Material market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Chemical & Material market has been broken down by major regions, with complete market estimates on the basis of products/applications on a regional basis.

Browse full research report at https://www.crystalmarketreport.com/global-metformin-hydrochloride-market-research-and-forecast-2019

Crystal Market Reports

Metformin Hydrochloride is the raw material of finished product metformin hydrochloride drugs. That is the API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents.

Metformin Hydrochloride is the raw material of finished product metformin hydrochloride drugs. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in the management of type 2-diabetes. With the accelerated pace of life and increasing aging population, global morbidity and mortality of diabetes disease increased year by year. Metformin hydrochloride is an efficient solution to the diseases. With increasing downstream demand, global Metformin hydrochloride API production also increased from 20267 MT in 2011 to 30374 MT in 2015, with CAGR of 10.64%.

Raw materials of Metformin hydrochloride are mainly hydrochloric acid and dimethylamine etc. The raw materials are common and the price is relative steady in the past few years. For the API product, there are many manufacturers in China, such as Shouguang Fukang Pharmaceutical, CR Double-Crane, Keyuan Pharmaceutical and Shijiazhuang Polee Pharmaceutical. Shouguang Fukang Pharmaceutical is also a global leader in this industry. In 2015, Metformin hydrochloride production value of Shouguang Fukang Pharmaceutical was about 18.0 Million USD.

The global Metformin Hydrochloride market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Metformin Hydrochloride volume and value at global level, regional level and company level. From a global perspective, this report represents overall Metformin Hydrochloride market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

Bristol-Mayers Squibb

Shouguang Fukang Pharmaceutical

Harman Finochem

Vistin Pharma

CR Double-Crane

Keyuan Pharmaceutical

FARMHISPANIA GROUP

Shijiazhuang Polee Pharmaceutical

Merck Sante

Aarti Drugs

TEVA

Taj API

Wanbury

Segment by Regions

North America

Europe

China

Japan

Segment by Type

Metformin HCL

Metformin DC

Others

Segment by Application

Metformin Hydrochloride Tablets

Metformin Hydrochloride Extended-Release Tablets

Others form

Browse full research report at https://www.crystalmarketreport.com/global-metformin-hydrochloride-market-research-and-forecast-2019

Reasons to Buy This Research Report

About Crystal Market Reports

Crystal Market Reports is a distributor of market research spanning 160 industries. Our extensive database consists of over 400,000 quality publications sourced from 400 plus publishers, this puts our research specialists in the unique position of been able to offer truly unbiased advice on what research provides the most valuable insights.

Contact Info.:-

Address: 90 State Street
Suite 700 Albany
New York 12207
Email: [email protected]
Web: https://www.crystalmarketreport.com